MAP Pharmaceuticals, Inc.

MAP Pharmaceuticals, Inc., a development stage company, focuses on the development and commercialization of inhalation therapies for patients suffering from migraine.

Ticker:
MAPP
Exchange:
NASDAQ (See More NASDAQ Companies)
Sector:
Healthcare (See More Healthcare Companies)